US Stock MarketDetailed Quotes

CRMD CorMedix

Watchlist
  • 8.295
  • -0.085-1.01%
Trading Dec 16 09:31 ET
503.32MMarket Cap-10.37P/E (TTM)

CorMedix Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CorMedix Q3 2024 Earnings Date

Currency：USDOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
10.84M
11.46M
+617.12K
Beat Est.
--
--
+5.69%
EPS
-0.10
-0.05
+0.05
Beat Est.
+38.26%
+70.59%
+52.34%
Analyst Rating
Strong Buy

Dec 16, 2024

CorMedix Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 31.017M--
--2024/Q4-- / 19.790M--
Oct 30, 20242024/Q311.456M / 10.839M--
Aug 14, 20242024/Q2806.120K / 1.674M--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 31.017M--
--2024/Q4-- / 19.790M--
Oct 30, 20242024/Q311.456M / 10.839M--
Aug 14, 20242024/Q2806.120K / 1.674M--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

CorMedix Earnings Reports

  • CorMedix | 10-Q: Q3 2024 Earnings Report

    Oct 30 08:22 ET

  • CorMedix | 8-K: CorMedix Inc. Reports THIRD Quarter AND NINE MONTH 2024 Financial Results and Provides Business Update

    Oct 30 08:01 ET

  • CorMedix | 10-Q: Q2 2024 Earnings Report

    Aug 14 08:19 ET

  • CorMedix | 8-K: CorMedix Inc. Reports SECOND Quarter AND SIX MONTH 2024 Financial Results and Provides Business Update

    Aug 14 08:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 16, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data